Journal Abbreviation: CANCER RES Journal ISSN: 0008-5472 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.5253122978 202211.2-141481 202113.312-161957 202012.701453159236 20199.727536135753 20188.378555130932 20179.130632139291 20169.122648139655 ...
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)9.127440118 20229.7-43634 20219.756-45756 20208.67939342174 20197.36042634162 20186.50852830146 20176.49147229311 20166.37548926657 20155.99251523851 20145.62142122516 20135.01650620626 20124.25834819352 ...
Advanced science. 2019;6(6):1801868. Article PubMed PubMed Central Google Scholar Yan Y, Cao S, Liu X, Harrington SM, Bindeman WE, Adjei AA, et al. CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight. 2018;3...
National Science Foundation Graduate Research Fellowship and the Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program. K.J.M. was supported by an American Cancer Society–2017 Seattle Gala Paddle Raise Postdoctoral Fellowship (PF-18-118-01-CDD) and the Program for Breakthrough ...
Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial–mesenchymal transition. Front. Oncol. 4, 59 (2014). Fried, M. & Duffy, P. E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272, 1502–1504 (1996). ...
This work was supported by the Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (GKE-KF202402), National Natural Science Foundation of China (Grant numbers 81973524), Special funds for science and technology development under the guidance of the central govern...
Disseminated cancer cells frequently lodge near vasculature in secondary organs. However, our understanding of the cellular crosstalk invoked at perivascular sites is still rudimentary. Here, we identify intercellular machinery governing formation of a p
; National Natural Science Foundation of China (U21A20356 to X.F, 82202875 to X.S.); ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University (02020200-K02013007 to X.L.); the Fundamental Research Funds for the Central Universities (226–2022-00214 to X.L.); ...
Immune checkpoint blockade (ICB) approaches have changed the therapeutic landscape for many tumor types. However, half of cutaneous squamous cell carcinoma (cSCC) patients remain unresponsive or develop resistance. Here, we show that, during cSCC progres
Immune checkpoint inhibitors (ICIs) have emerged as a novel and effective treatment strategy, yet their effectiveness is limited to a subset of patients. The gut microbiota, recognized as a promising anticancer adjuvant, is being increasingly suggested t